OR WAIT null SECS
February 02, 2005
The Impurity Profiling Group reviews stress testing according to regulatory guidance documents. The authors emphasize what should be considered for late clinical phases and for registration application dossiers.
January 20, 2005
Albumin-Bound Nanoparticle Drug Nabs FDA Approval
January 11, 2005
Cellular Chemical Factory Lowers Cost of Malaria Treatment
January 07, 2005
Engineered Oilbodies Produce Vaccines and Adjuvants
January 06, 2005
January 02, 2005
The author reviews the effects of moisture on flow properties, tensile strength, Heckel plot, energies involved in compaction, and elastic recovery.
From solving complex formulation challenges to delivering full product-development programs, outsourcing services organizations provide valuable expertise, experience, and technical know-how.
The authors examine the effects of three superdisintegrants on the dissolution and absorption of tenoxicam from solid-dispersion formulations.
January 01, 2005
This article examines the different types of dessicants avaliable to the pharmaceutical industry. It provides information on choosing the right type, and how and when it should be used.
December 02, 2004
Microspheres of Eudragit RL were developed for colonic delivery of albendazole. The effects of polymer concentration, stirring rate, and concentration of emulsifier on particle size and drug loading were studied. A comparative in vitro drug release study of the optimized formulation was carried out.